![]() |
|
|
Vol. 57, Issue 3, 610-618, March 2000
Institut für Klinische Chemie und Pathobiochemie der
Justus-Liebig-Universität Gie Heme oxygenase (HO) catalyzes the rate-limiting enzymatic step of heme
degradation and regulates the cellular heme content. The gene
expression of the inducible isoform of HO, HO-1, is up-regulated in
response to various agents causing oxidative stress. To investigate the
regulatory role of protein phosphatases in the hepatic regulation of
HO-1 gene expression, primary cultures of rat hepatocytes were treated
with okadaic acid (OA), which specifically inhibits the serine
threonine protein phosphatases 1 and 2A. Both protein synthesis and
mRNA expression of HO-1 were induced by OA in cultured hepatocytes, but
not in cultured tissue macrophages of rat liver. The HO-1 mRNA
induction by OA occurred in a time- and concentration-dependent manner.
Simultaneous treatment with OA plus dibutyryl cAMP caused a synergistic
up-regulation of steady-state levels of HO-1 mRNA, and the specific
protein kinase A inhibitor KT5720 markedly reduced the OA-dependent
HO-1 mRNA induction. In contrast, the dibutyryl cAMP-dependent
induction of the phosphoenolpyruvate carboxykinase mRNA expression and
enzyme activity was inhibited by simultaneous treatment with OA in
hepatocytes. The induction of the HO-1 gene expression by OA was
transcriptional as determined by studies with actinomycin D, nuclear
run-off assay, and measurement of the half-life of HO-1 mRNA.
Luciferase reporter constructs containing DNA sequences of the rat HO-1
promoter 5'-flanking region were up-regulated by OA in transiently
transfected hepatocytes. Mutation of the cAMP response
element/activator protein-1 (
en, Gie
en (S.I., V.H., N.K.);
and Institut für Biochemie und Molekulare Zellbiologie der
Georg-August-Universität Göttingen, Göttingen,
Germany (T.K.)
665/
654) site obliterated the
OA-dependent induction, suggesting that this element is involved in the
transcriptional induction of the rat HO-1 gene by OA.
This article has been cited by other articles:
![]() |
S. W. Ryter, J. Alam, and A. M. K. Choi Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications Physiol Rev, April 1, 2006; 86(2): 583 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Wijayanti, T. Kietzmann, and S. Immenschuh Heme Oxygenase-1 Gene Activation by the NAD(P)H Oxidase Inhibitor 4-(2-Aminoethyl) Benzenesulfonyl Fluoride via a Protein Kinase B, p38-dependent Signaling Pathway in Monocytes J. Biol. Chem., June 10, 2005; 280(23): 21820 - 21829. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Heinloth, R. D. Irwin, G. A. Boorman, P. Nettesheim, R. D. Fannin, S. O. Sieber, M. L. Snell, C. J. Tucker, L. Li, G. S. Travlos, et al. Gene Expression Profiling of Rat Livers Reveals Indicators of Potential Adverse Effects Toxicol. Sci., July 1, 2004; 80(1): 193 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Sikorski, T. Hock, N. Hill-Kapturczak, and A. Agarwal The story so far: molecular regulation of the heme oxygenase-1 gene in renal injury Am J Physiol Renal Physiol, March 1, 2004; 286(3): F425 - F441. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. D. T. G. Wagener, H.-D. Volk, D. Willis, N. G. Abraham, M. P. Soares, G. J. Adema, and C. G. Figdor Different Faces of the Heme-Heme Oxygenase System in Inflammation Pharmacol. Rev., September 1, 2003; 55(3): 551 - 571. [Abstract] [Full Text] [PDF] |
||||